Company intelligence
Hello Heart
AI company building a platform to predict and prevent cardiac events before they happen.
About Hello Heart
Hello Heart envisions a world where heart attacks are a thing of the past. We’re an AI company focused exclusively on heart health, building a platform to predict and prevent cardiac events before they happen—identifying risk up to 10 days in advance versus 10-year risk estimates from traditional clinical models. Proven at scale, Hello Heart has been shown to reduce inpatient hospital days by 47% and deliver more than $1,700 in annual healthcare savings per member. Hello Heart is the cardiac prevention partner to over 80% of large U.S. health plans and serves hundreds of public and private employers. We collaborate with leading organizations including CVS Health and the American College of Cardiology to expand access to preventive heart health technology. Fast Company named Hello Heart one of the most innovative companies of 2026. Learn more at www.helloheart.com.
Verified activity
Signals from Hello Heart
15 published signals
People
Hello Heart welcomed Omri Shor as Entrepreneur-in-Residence to expand preventive health AI through strategic partnerships and innovation.
Reported by Hello Heart
Research & Knowledge
Hello Heart reported that the HORIZON trial did not meet its primary endpoint of cardiovascular death, non-fatal MI, non-fatal stroke, and urgent coronary revascularization requiring hospitalization.
Reported by Jayne Morgan, M.D.
Presence & Recognition
Hello Heart featured Jack Eltman as a user and trustee of IAFF 22.
Reported by Bianca Lopez